Oculis SA and EBAC join to drive ophthalmology innovation

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisi

Report: Reinventing product and portfolio value for the biop...

Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing ne

Practical advice for Early Scientific Advice (ESA) in HTA su...

How digital is transforming the commercial leader’s role in ...

Pharma’s evolving role in patient care